This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Natac Adopts Olive Through The American Botanical Council's Adopt-an-Herb Program

AUSTIN, Texas, Jan. 29, 2013 /PRNewswire-USNewswire/ -- The American Botanical Council (ABC) announces that Natac, a natural products and biotechnology company headquartered in Spain, officially has adopted olive ( Olea europaea) through ABC's Adopt-an-Herb Program. Natac's three-year commitment will help ABC keep its HerbMedPro database up-to-date with the latest scientific and clinical research on olive. HerbMedPro is an interactive and comprehensive database, available at ABC's website, that provides access to important scientific and clinical research data underlying the use of herbs for health.


"ABC is deeply grateful to Natac for their adoption of olive," said ABC Founder and Executive Director Mark Blumenthal. "Their participation in this program will ensure that information on olive preparations in the HerbMedPro database will stay current, all while supporting ABC's nonprofit educational mission. It seems that almost every week or month there are new studies coming out on the health benefits of consumption of olive oil or olive extracts, making this an especially timely adoption."

Natac joins 15 other herb and plant-based ingredient companies that have come forward to support ABC's ongoing efforts through the Adopt-an-Herb Program to collect, organize, and disseminate reliable, traditional, and science-based information on herbs, medicinal plants, and other botanical-based ingredients. Adopt-an-Herb encourages companies and individuals to "adopt" one or more specific herbs for inclusion and ongoing maintenance in the HerbMedPro database. Each adopted herb is continuously researched for new articles and studies, ensuring that its HerbMedPro record stays current and robust. The result is an unparalleled resource for consumers, researchers, healthcare practitioners, educators, media, government agencies, members of industry, and others, available via ABC's information-rich website.

HerbMedPro is an interactive, impartial, and evidence-based database that provides online access to abstracts of scientific and clinical publications on more than 250 commonly used medicinal herbs. Herb records in the database vary in size from those with a very large amount of published data — such as Ginkgo biloba, with more than 1,000 summarized entries and links — to Acacia catechu (cutch tree or black catechu in the pea family), with fewer than 50. Each abstract is also summarized in only one sentence, thereby saving a significant amount of time for the user.

HerbMedPro is available to ABC members at the Academic level and higher; its "sister" site HerbMed, however, is free and available to the general public. HerbMed features 20 to 30 herbs from HerbMedPro that are rotated on a regular basis. Making this unique resource free to the public increases the number of people benefiting from updated information on herbs, in accordance with ABC's nonprofit educational mission.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,776.43 +304.06 1.85%
S&P 500 1,987.05 +35.69 1.83%
NASDAQ 4,781.2640 +73.4890 1.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs